Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers

Clinical trial NCT04553692 · TERMINATED

Trial details

NCT number

NCT04553692

Sponsor

IGM Biosciences, Inc.

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2020-09-23

Primary completion

2025-01-20

Enrollment

272

View on ClinicalTrials.gov